RiverFront Investment Group, LLC

Position in MRK — Merck & Co., Inc.

CIK 1469751 RICHMOND, VA

Position in MRK

as of Jun 30, 2026 · filed Jul 29, 2026 Compact

Position Value

$10,002,825

+$3,507,887 QoQ

Shares Held

77,843

+44.2% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.49%

of 13F equity value

Holder Rank

#746

of 3,769 holders

Holding Since

Jun 2021

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

RiverFront Investment Group, LLC holds $89,602,289 across 9 Drug Manufacturers - General names. MRK ranks #4 (11.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	32,968	$39,542,811
2	JNJ	Johnson & Johnson	64,265	$16,321,382
3	ABBV	AbbVie Inc.	59,624	$15,003,783
4	MRK	Merck & Co., Inc. This page	77,843	$10,002,825
5	AMGN	Amgen Inc	13,012	$4,711,905
6	BMY	Bristol Myers Squibb Co	32,862	$1,893,508
7	PFE	Pfizer Inc	45,974	$1,107,053
8	GILD	Gilead Sciences, Inc.	5,103	$644,713

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$10,002,825	77,843	+44.2%	Shares	Sole	2026-07-29
2026-03-31	$6,494,938	53,994	+123.1%	Shares	Sole	2026-05-11
2025-12-31	$2,547,818	24,205	+4.6%	Shares	Sole	2026-02-05
2025-09-30	$1,941,888	23,137	+15.1%	Shares	Sole	2025-11-13
2025-06-30	$1,591,511	20,105	+19.0%	Shares	Sole	2025-08-12
2025-03-31	$1,517,033	16,901	+29.1%	Shares	Sole	2025-05-14
2024-12-31	$1,302,093	13,089	+7.6%	Shares	Sole	2025-02-12
2024-09-30	$1,381,343	12,164	+14.4%	Shares	Sole	2024-11-08
2024-06-30	$1,315,870	10,629	+0.4%	Shares	Sole	2024-08-28
2024-03-31	$1,397,350	10,590	-1.9%	Shares	Sole	2024-08-28
2023-12-31	$1,176,652	10,793	+190.9%	Shares	Sole	2024-08-28
2021-06-30	$288,526	3,710	—	Shares	Sole	2021-08-09
No filing history on record for this holder in this stock.